ABSTRACT
MATERIALS AND METHODS
Isolation of Lin-Mononuclear Cells. BM mononuclear cells from 3-to 6-week old mice and day 12 to 13 FL mononuclear cells free of erythrocytes from p53-deficient homozygous (ref.
11; purchased from GenPharm, Mountain View, CA) or normal C57BL/6 mice (bred and maintained in the animal barrier facility of our department) were prepared as described (12, 13) . Lin-BM and FL cells were obtained by removing CD4+, CD8+, CD3+, IgM+, Joro 75+, B-220+, F4/80+, 8C5+, and TER 119+ cells by a combination of negative selection using magnetic beads and positive selection by fluorescenceactivated cell sorter (FACS) as described in detail (12, 14) . A proportion of the cell sorter-selected cells were used for reanalysis and showed that >99.5 of the cells were negative for all the surface markers indicated above and they will be referred to as Lin-cells. The FL or BM Lin-cells were washed and resuspended in culture medium [Iscove's modified Dulbecco's medium supplemented with 7.5-10% heat-inactivated defined fetal bovine serum (cat. no. A-1111, HyClone), 2-mercaptoethanol (5 x 105 M), 2 mM L-glutamine, and gentamycin (50 ttg/ml)].
Cytokines. Recombinant interleukin (IL)-ll3 was a gift from Hoffmann-LaRoche (Basel, Switzerland). Supernatants were from X63Ag8 or J558/L myeloma cells transfected with cDNAs coding for mouse (m)IL-2, mIL-3, mIL-4, mIL-5, human (h)IL-6, (15) mIL-7 (16), or hIL-10 [plasmid pHIL-10-550p, gift of P. Dellabona (H. S. Raffaele, Milan)]. Cos-1 cells were transfected with cDNA coding for steel factor (13) and cDNA coding for human leukemia-inhibiting factor (hLIF) (plasmid pC10-6R, gift from A. Smith, Centre for Animal Genome Research, Edinburgh). cDNA coding for basic fibroblast growth factor (plasmid pbFGF) was a gift of G. Neufeld (Israel Institute of Technology, Haifa). mIL-9 was a gift of J. Van Snicke (University of Brussels, Belgium); B9-transfected cells producing IL-11 were provided by R. G. Hawley (University of Toronto). J558/L/FLT3-lig/5 transfectant cells producing recombinant mouse FLT3-lig were developed by subcloning FLT3/FLK2-mouse cDNA into the EcoRI-XhoI site of the pCDNA3 mammalian expression vector (X.X. and R.P., unpublished results), erythropoietin, macrophage colonystimulating factor (CSF), granulocyte CSF, tumor necrosis factor a, transforming growth factor ,B, and IL-12 were purchased from R & D Systems, and mouse granulocyte/ macrophage CSF was a gift from Biogen. The cell-free supernatants collected and filtered from 2-to 3-day confluent cultures of the FLS4.1 stromal cell line are referred to as F (13 
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were found. phycoerythrin-anti-rat IgG, and phycoerythrin-streptavidin were from Southern Biotechnology Associates; FITCstreptavidin was from Vector Laboratories; FITC-conjugated anti-rat IgG, mouse Ig, and rat Ig were from Jackson ImmunoResearch; and FITC-anti-rat IgM was from The Binding Site (Birmingham, U.K.). The antibodies against the following cell surface markers were prepared in our laboratory: Joro 37-5, 75, 96, 184, 177; PgP-1 (1/45), c-Kit (ACK2), LFA-1 (FD441.8), and HSA (JllD) (12) (13) (14) .
Northern Blot and Reverse Transcriptase-PCR assays.
Northern blot assays using total RNA (20 ,ug per lane) were performed as described (12, 13) with 32P-labeled specific probes for the genes indicated. The reports describing the origin and characteristics of these probes are listed elsewhere (12, 13) . The generation of cDNAs, the primer combinations, and cycle protocols used in reverse transcriptase-PCR assays for the CD34, Tal-1, E12, Gata-2, Id-1, and CD19 genes will 
RESULTS AND DISCUSSION
To find culture conditions that support long-term growth of undifferentiated PHSCs, we thought that it would be advantageous to use PHSCs from mutant mice that lack the p53 gene (i1, 18, 19) . PHSCs from p53-deficient mice might survive longer in culture and might have a lower threshold to enter into mitosis. p53 controls the G1 to S phase transition of the cell cycle without affecting hematopoiesis (11, 18, 19) . Enriched populations of PHSCs from day 12-13 FL cells or BM of young adult p53-deficient mice were obtained by a combination of negative selection using magnetic beads and positive selection by FACS (12, 14) . Two cytokine combinations out of several tested were found to support proliferation with no or little differentiation, namely, LIF, steel factor, F (supernatants from the FLS4.1 FL stromal cell line), and either IL-3 or FLT3-lig. These mixtures will be referred to as 3LSF or FLT3-ligLSF, respectively. If F is removed from the cytokine mixture, the cells will continue to proliferate but will also differentiate, usually into F4/80, 8C5, and TER 119-positive myeloid/ erythroid cells. Both 3LSF and FLT3-ligLSF-conditioned medium supported the initiation and long-term (>6 months) maintenance of PHSC lines. In cultures that received FLT3-ligLSF medium, the frequency of positive wells (12-19%) Northern blot analysis revealed the absence of RNA transcripts for genes expressed at very early stages of lymphocyte development (CD3-y, CD3C, Rag-1, Rag-2, TCF-1, Gata-3, LEF-1, MB-1, vPRE-B, A5, ,u Ig heavy chain, and TCR6), and of Gata-1 mRNA expressed at early stages of erythroid/ myeloid differentiation ( Fig. 1 and Table 1 ). All clones synthesized mRNA for the A3 nuclear transport gene and for the A52 gene encoding ribosomal protein L13 (unpublished results; Fig. 1 ). Reverse transcriptase-PCR assays revealed that all four clones synthesize RNA for CD34 and for Tal-1, Gata-2, E12, and Id-1 transcriptional regulator genes and were negative for CD19 B-cell lineage specific gene (Table 1) . These results indicate that the Lin-p53-and the Lin-pS3+ clones are at an earlier stage of differentiation than lymphoid-, erythroid-, and myeloid-committed progenitors. In addition, the phenotypic and genotypic characteristics readily distinguish these clones from previously described multipotent, pro-B cell, pro-T cell, B-cell/myelocytic, and myeloid progenitor cell lines (12, 13, 21 ).
The clones were tested for their capacity to provide longterm reconstitution of the hematopoietic system ofx-irradiated mice. We and others (14, 22) have shown before that sublethally irradiated SCID mice are well-suited to assess the differentiation of not only lymphocyte precursors but also lymphohematopoietic stem cells. The SCID mutation renders cells more sensitive to x-irradiation and hampers their hematopoietic recovery after nonlethal doses of radiation (22) . This provides with a competitive assay between host PHSCs and the PHSC population under test without the need to expose the recipients to lethal doses of irradiation, which may cause severe damage of the microenvironments required for survival and differentiation of PHSCs.
Two markers were used to distinguish the hematopoietic progeny of the donor cells (Lin-clones) from C3H-SCID recipient cells, namely, H-2b assessed using an MHC class I H-2b specific antibody and FACS analysis (12, 14) and the Neor gene [present in the genome of the p53-deficient mice (11) ] assessed by DNA-based PCR (12, 14) ]. We have shown <1  <1  <1  <1  <1  2  6  <1  <1  <1  <1  <1  <1  3  5  <1  <1  <1  <1  <1  <1  4  5  <1  <1  <1  <1  <1  <1 The clones (106 cells per mouse) or control buffer without cells were injected into sublethally irradiated C3H SCID mice (H-2K). Five to 6 months later, the presence of donor-derived (H-2b+) cells in the BM and spleen was determined by two-color FACS analysis. clones have the capacity to provide long-term reconstitution of the lymphohematopoietic system. In another set of experiments, we studied whether the Linclones could rescue mice from a lethal dose of radiation. Thus, the Lin-p53-and the Lin-p53+ clones from normal mice were injected i.v. either alone or together with BM cells from Rag-2-deficient mice into lethally irradiated syngeneic Rag-2-deficient mice. Control groups included irradiated mice that received either no cells or marrow cells from Rag-2-deficient mice only. Survival of the mice was monitored daily during the first 20 days and twice weekly aftewards. The presence of donor-derived mature T and B lymphocytes in the mice that survived was monitored by FACS analysis of peripheral blood for the presence of TCRab+ mature T lymphocytes and IgM+ mature B lymphocytes. Rag-2-deficient mice cannot rearrange their antigen receptor-encoding genes and thereby do not have mature T and B lymphocytes (17) . Thus, the presence of mature T and/or B lymphocytes in the Rag-2-deficient mice will indicate that these mature lymphocytes are the progeny of the Lin-clones injected. Table 3 shows that lethally irradiated Rag-2-deficient mice that received the p53-Lin-clones or the p53+ Lin-clones alone all died between 5 and 14 days after exposure to a lethal dose of irradiation, as did the control group of mice that received no cells. The Lin-clones failed by themselves to rescue lethally irradiated mice at all cell concentrations tested (106, 5 x 106, and 107 cells per mouse). The latter also precluded to assess their potential to give rise to CFU-S, a property of less immature progenitor cells than PHSCs (2, 23) . In contrast, all lethally irradiated Rag-2-deficient mice that received the Lin-p53-clones or the Linp53+ clones together with few marrow cells from Rag-2-deficient mice survived during the period of observation (6 months). These mice had mature T-and B-lymphocytes (range of percentages of TCRab+ plus IgM+ mature lymphocytes detected was 37% to 63% 6 months after transfer of the Linclones) generated by the Lin-lymphohematopoietic precursor clones injected (Table 3 ). The latter results ruled out the possibility that the Lin-clones were unable to survive, engraft, and differentiate in these lethally irradiated mice. Eight out of 10 lethally irradiated Rag-2-deficient mice that received only BM cells from Rag-2-deficient mice survived, but none of these mice had detectable mature T or B lymphocytes ( Table  3 ). The finding that the Lin-p53-and the Lin-p53+ lymphohematopoietic precursor clones could not by themselves rescue mice from a lethal dose of radiation agree with some (23, 24) but not with other (2, 25) previous studies in which the ability of freshly isolated enriched PHSC populations to rescue mice from lethal irradiation was also investigated. There are several potential explanations for these contrasting results. For instance, the PHSC population might be heterogenous in terms not only of cell cycle status, rhodamine 123 staining, and size (2, 9, 10), but also in their ability to rescue mice from a lethal dose of irradiation. The clones described here would represent the PHSC subset that lacks this property. Another explanation is that a few more differentiated precursor cells contained in a given preparation of freshly isolated enriched PHSC cells could account for survival of lethally irradiated mice. The latter implies that PHSCs would not possess the capacity of rescuing mice from a lethal dose of irradiation (23, 24) and would be consistent with the results obtained here with the Lin-clones. Although this possibility is virtually impossible to rule out in experiments using freshly isolated enriched PHSC populations, a recent study reported that as few as 25 cells from a purified BM PHSC cell population were able to protect one-third of irradiated recipient mice, and 100 cells protected all recipients (25) , findings that argue against this explanation. A third possibility is that the Linp53-and the Lin-p53+ clones, while retaining the functions of extensive self-renewal and lymphohematopoietic precursor potential, might have lost, after prolonged culture, the ability to rescue mice from a lethal dose of radiation. Further work is necessary to distinguish among these possibilities. (12, 14) . The primers 5'-NeoTTCGGCTATGACTGGGCACAAC and 3'-NeoTCAGTGA-CAACGTCGAGCACA and the Neo-specific probe (the 1.4-kb HindIII-SmaI fragment of the PSV-2 Neo plasmid) were used. The PCR products were fractionated on agarose gels, blotted to nitrocellulose filters, and hybridized with 32P-labeled Neo-specific probe, followed by autoradiography. Exposure times were usually between 2 and 6 hr. The presence of Neor-positive cells unambigously documents that these cells were the progeny of the BMp53-A11 clone, which carries the Neor gene in its genome and distinguishes it from hematopoietic cells of SCID host or FL cells from C57BL/6 normal mice origin, which do not. In summary, we show here that lymphohematopoietic stem cells can grow in long-term cultures without differentiating. The clones from normal and p53-deficient mice described here share phenotypic characteristics and the two functions of PHSC with the freshly isolated populations enriched for PHSC; these are, namely, the ability to provide long-term repopulation of the hematopoietic system and the capacity of giving rise to lymphoid, myeloid, and erythroid cell lineages. Among the individual cytokines in the mixtures (IL-3, LIF, FLT3-lig, steel factor, and F) found here to be required to support proliferation of PHSCs without differentiation, IL-3, LIF, FLT3-lig, and steel factor have previously been reported to have direct or indirect effects on PHSCs (26) (27) (28) (29) . The new component in the mixture called F [cell-free supernatants from the FLS4.1 stromal cell line (13) ], remains to be characterized. Our attempts to replace F with known cytokines such as IL-1-IL-12, tumor necrosis factor, transforming growth factor, FLT3-lig, GM-CSF, M-CSF, G-CSF, activin, and fibroblast growth factor have been unsuccessful. Efforts toward the molecular cloning of the active moiety in F are currently underway.
The availability of continuously proliferating lymphohematopoietic stem cell clones offers a unique opportunity to study many aspects of the biology of these cells-for instance, the isolation of new genes active in these cells, the possibility of identifying specific surface markers for PHSCs, and, most attractive to us, the molecular mechanisms that control selfrenewal and differentiation.
